For example, the cost of anti-VEGF therapy for several retinal diseases, such as age-related macular degeneration and DR can be substantial, with studies reporting a wide range of treatment costs depending on the specific medication and treatment regimen [107]. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.